Document is current
Any future updates will be listed below
-
Authors
Capelo-Avilés, Santiago https://orcid.org/0000-0001-7656-3967
de Fez-Febré, Mabel
Balestra, Salvador R. G. https://orcid.org/0000-0002-2163-2782
Cabezas-Giménez, Juanjo https://orcid.org/0000-0002-8424-7101
Tomazini de Oliveira, Raiana https://orcid.org/0000-0003-4905-2197
Gallo Stampino, Irene I.
Vidal-Ferran, Anton
González-Cobos, Jesús https://orcid.org/0000-0003-0885-5815
Lillo, Vanesa
Fabelo, Oscar https://orcid.org/0000-0001-6452-8830
Escudero-Adán, Eduardo C. https://orcid.org/0000-0002-9771-1735
Falvello, Larry R. https://orcid.org/0000-0002-0444-996X
Parra, José B. https://orcid.org/0000-0002-8802-5856
Rumori, Paolo
Turnes Palomino, Gemma
Palomino Cabello, Carlos https://orcid.org/0000-0002-3191-1232
Giancola, Stefano https://orcid.org/0000-0002-3638-366X
Calero, Sofia https://orcid.org/0000-0001-9535-057X
Galán-Mascarós, José Ramón https://orcid.org/0000-0001-7983-9762
- License Information
-
More Information
Article History
Received: 2 September 2024
Accepted: 17 March 2025
First Online: 4 April 2025
Competing interests
: The authors declare the following competing financial interest(s): V.L. and J.R.G.M. are inventors in European patent application No.: EP16382480.8, filed by ICIQ and ICREA (Priority date: 21/10/2016), protecting the chemical structure of TAMOF-1 and its derivatives and analogs, along with their applications, including but not limited to their use in CO2 separation and purification. This patent has been licensed to Orchestra Scientific S.L., a spin-off company founded and participated by J.R.G.M., ICIQ, and ICREA. S.G. is the CTO of Orchestra Scientific S.L. The remaining authors declare no competing interests.
